Fulgent Genetics (FLGT) Accumulated Expenses (2016 - 2026)
Fulgent Genetics' Accumulated Expenses history spans 12 years, with the latest figure at $34.9 million for Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 603.22% to $34.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $34.9 million, a 603.22% increase, with the full-year FY2025 number at $5.2 million, down 78.43% from a year prior.
- Accumulated Expenses hit $34.9 million in Q1 2026 for Fulgent Genetics, up from $5.2 million in the prior quarter.
- Over the last five years, Accumulated Expenses for FLGT hit a ceiling of $34.9 million in Q1 2026 and a floor of $3.8 million in Q1 2024.
- Historically, Accumulated Expenses has averaged $18.1 million across 5 years, with a median of $21.7 million in 2025.
- Biggest five-year swings in Accumulated Expenses: crashed 82.15% in 2024 and later skyrocketed 603.22% in 2026.
- Tracing FLGT's Accumulated Expenses over 5 years: stood at $25.0 million in 2022, then tumbled by 77.02% to $5.7 million in 2023, then skyrocketed by 322.91% to $24.3 million in 2024, then tumbled by 78.43% to $5.2 million in 2025, then skyrocketed by 566.56% to $34.9 million in 2026.
- Business Quant data shows Accumulated Expenses for FLGT at $34.9 million in Q1 2026, $5.2 million in Q4 2025, and $23.0 million in Q3 2025.